CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- 4 Grant or award Director acquired 1,357 shares (grant or award)
- 4 Open-market sale Chief Technical Ops Officer sold 9,743 shares at $46.69 ($454,891)
- 144 Insider Sale of Securities
- 4 Open-market sale SVP, FINANCE sold 11,623 shares at an average $47.92 ($556,972)
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement
- 4 Shares withheld for taxes SVP, FINANCE gave up 482 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technical Ops Officer gave up 1,204 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 2,759 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CFO gave up 2,890 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 7,356 shares (to pay taxes)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes SVP, FINANCE gave up 567 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technical Ops Officer gave up 1,538 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 4,286 shares (to pay taxes)
Page 7 of 39 · 770 filings